Compounds > 4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline
Page last updated: 2024-10-29

4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline and Graft vs Host Disease

4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline has been researched along with Graft vs Host Disease in 2 studies

WHI P131: a quinazoline derivative, inhibitor of glioblastoma cell adhesion and migration

Graft vs Host Disease: The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cetkovic-Cvrlje, M2
Uckun, FM2
Roers, BA1
Waurzyniak, B1
Liu, XP1

Other Studies

2 other studies available for 4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline and Graft vs Host Disease

ArticleYear
Dual targeting of Bruton's tyrosine kinase and Janus kinase 3 with rationally designed inhibitors prevents graft-versus-host disease (GVHD) in a murine allogeneic bone marrow transplantation model.
    British journal of haematology, 2004, Volume: 126, Issue:6

    Topics: Acute Disease; Agammaglobulinaemia Tyrosine Kinase; Amides; Animals; Bone Marrow Transplantation; Dr

2004
Targeting Janus kinase 3 to attenuate the severity of acute graft-versus-host disease across the major histocompatibility barrier in mice.
    Blood, 2001, Sep-01, Volume: 98, Issue:5

    Topics: Acute Disease; Animals; Bone Marrow Transplantation; Cell Transplantation; Drug Evaluation, Preclini

2001